Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells, a model for nasal epithelial permeability
- 2 September 2012
- journal article
- research article
- Published by Springer Nature in Cytotechnology
- Vol. 65 (3) , 395-406
Abstract
The nasal pathway represents an alternative route for non-invasive systemic administration of drugs. The main advantages of nasal drug delivery are the rapid onset of action, the avoidance of the first-pass metabolism in the liver and the easy applicability. In vitro cell culture systems offer an opportunity to model biological barriers. Our aim was to develop and characterize an in vitro model based on confluent layers of the human RPMI 2650 cell line. Retinoic acid, hydrocortisone and cyclic adenosine monophosphate, which influence cell attachment, growth and differentiation have been investigated on the barrier formation and function of the nasal epithelial cell layers. Real-time cell microelectronic sensing, a novel label-free technique was used for dynamic monitoring of cell growth and barrier properties of RPMI 2650 cells. Treatments enhanced the formation of adherens and tight intercellular junctions visualized by electron microscopy, the presence and localization of junctional proteins ZO-1 and β-catenin demonstrated by fluorescent immunohistochemistry, and the barrier function of nasal epithelial cell layers. The transepithelial resistance of the RPMI 2650 cell model reached 50 to 200 Ω × cm2, the permeability coefficient for 4.4 kDa FITC-dextran was 9.3 to 17 × 10−6 cm/s, in agreement with values measured on nasal mucosa from in vivo and ex vivo experiments. Based on these results human RPMI 2650 cells seem to be a suitable nasal epithelial model to test different pharmaceutical excipients and various novel formulations, such as nanoparticles for toxicity and permeability.Keywords
This publication has 47 references indexed in Scilit:
- The effect of sucrose esters on a culture model of the nasal barrierToxicology in Vitro, 2012
- New aspects of the molecular constituents of tissue barriersJournal of Neural Transmission, 2010
- Sodium hyaluronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissueEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Role of retinoic receptors in lung carcinogenesisJournal of Experimental & Clinical Cancer Research, 2008
- Evaluation of human nasal RPMI 2650 cells grown at an air–liquid interface as a model for nasal drug transport studiesJournal of Pharmaceutical Sciences, 2008
- Compound Cytotoxicity Profiling Using Quantitative High-Throughput ScreeningEnvironmental Health Perspectives, 2008
- Intranasal delivery: Physicochemical and therapeutic aspectsInternational Journal of Pharmaceutics, 2007
- Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and PharmacologyCellular and Molecular Neurobiology, 2005
- Human tumor cell line with a quasi-diploid karyotype (RPMI 2650)Experimental Cell Research, 1965
- Studies of a human tumor cell line with a diploid karyotypeCancer, 1964